Prostate cancer advances help extend a patient's life

September 11, 2018 | Dory Benford

Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.

Continue Reading

New hormone and immunotherapy trial for breast cancer patients

October 8, 2019 | City of Hope

This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.

A triple-negative breast cancer trial has its first success story

October 12, 2018 | Maxine Nunes

Linda Collins's outlook was bleak, thanks to her triple-negative breast cancer diagnosis, until City of Hope oncologist Yuan Yuan, M.D., Ph.D. helped develop a revolutionary new trial to help her.

Crime fighters fight breast cancer with the Pink Patch Project

October 11, 2018 | Maxine Nunes

San Bernardino District Attorney Child Abduction Unit investigative tech and City of Hope breast cancer survivor Michelle Faxon and her law enforcement colleagues are involved with the Pink Patch Project to raise funds for breast cancer research.

City of Hope posts higher breast cancer survival rates at all stages

October 9, 2018 | City of Hope

City of Hope is proud of having higher survival rates at all stages of breast cancer than those of the Los Angeles Registry of the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program.

Diane Walker: Fighting breast cancer, one screening at a time

October 9, 2018 | Maxine Nunes

Early detection saved Diane Walker's life, and now she is working with City of Hope to raise awareness about breast cancer, in hopes more women will get checked out.

Patients over 60 needed for HER2-positive breast cancer study

October 7, 2018 | City of Hope

Researchers are actively recruiting for patients 60 years and older for a phase 2 trial studying the side effects of and how well neratinib works in treating older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer that has spread from where it started to other places in the body.

Cardiotoxicity and Breast Cancer

October 5, 2018 | Alison Shore

As a competitive open-water swimmer, Nancy Clifton-Hawkins has always welcomed a challenge. She just never envisioned it coming in the form of cardiotoxicity related to her breast cancer treatment.

Lumpectomy vs. Mastectomy: Making a Decision

October 3, 2018 | Kevin Chesley

Amy Polverini, M.D., surgical oncologist at City of Hope, sheds some light on all of the factors to be considered when choosing between a lumpectomy or a mastectomy.

What Is Metastatic Triple-negative Breast Cancer?

October 2, 2018 | Kevin Chesley

City of Hope's Yuan Yuan, M.D., Ph.D, knows that those faced with metastatic triple-negative breast cancer have a tough fight ahead of them, but she is working to make that battle more surmountable.

Latest Advances in Breast Cancer Screening

October 1, 2018 | Kevin Chesley

City of Hope uses the most state-of-the-art lab techniques and imaging strategies to screen patients and, should breast cancer be found, creates personalized treatment plans. Monique White-Dominquez, D.O., specializes in breast cancer screening.